COUR Pharmaceuticals Announces Positive Top-line Results from Phase 2a Study of CNP-104 in Primary Biliary Cholangitis
CNP-104 demonstrated potential efficacy across multiple immunological and clinical measurements, supporting its continued development as the first disease-modifying treatment for Primary Biliary ...
The American Journal of Managed Care6d
Venetoclax Plus Rituximab Supports Immune Recovery in CLL
Researchers report on the long-term immune changes in patients with refractory or relapsed chronic lymphocytic leukemia (CLL) ...
Targeted Oncology10d
Lunning Evaluates CAR T-Cell Therapy for ASCT-Eligible and Ineligible DLBCL
During a Case-Based Roundtable® event, Matthew A. Lunning, DO, discussed the updated trial data for 2 chimeric antigen ...
Vaccine experts report positive results on Phase 1 trial of personalized vaccine for lymphoplasmacytic lymphoma
A team of researchers from City of Hope and The University of Texas M.D. Anderson Cancer Center has reported safety and ...
GEN14d
Improving CAR-T Cell Efficacy via New Manufacturing Process
A new bioprocessing technique developed by a team of researchers could improve a range of therapies based on CAR-T cells.
BBC15d
Independence vote left 'positive legacy' - Swinney
The Scottish independence referendum left an "overwhelmingly positive legacy" on the country ... The first minister added: “As a nation, we can’t just regret the things that we cannot do ...
Nature15d
Antigen presentation in the thymus for positive selection and central tolerance induction
Interactions with self-peptide–MHC complexes on thymic epithelial cells are crucial for thymocyte survival (positive selection ... only in CD8 + but also in CD4 + T cell tolerance.
Cancer Research15d
TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer
Department of Medical Oncology, Erasmus MC, Rotterdam, the Netherlands. *Corresponding Author: Reno Debets, Laboratory of Tumor Immunology, Department Medical Oncology, Erasmus MC Cancer Institute, Be ...
Frontiers16d
Identifying immune checkpoints on dysregulated T-cells as prognostic biomarkers for multiple myeloma patients with COVID-19
The percentage of CD4+ and CD8+ subpopulation and immune checkpoints (PD ... An inhibition rate of ≥ 30 is regarded to be positive. T-cell response was measured by the IFN-γ release via ...
Android Authority17d
The history of cell phones: A decade-by-decade timeline
Motorola took a decade and $100 million to develop the first cell phone. However, Motorola wasn’t ready to put cell phones in their customers’ pockets yet. It would take a full decade and over ...
Nikkei Asia19d
U.S. to start steep China tariff hikes on EVs, solar cells, on Sept. 27
The U.S. Trade Representative's office said that many of the tariffs, including a 100% duty on Chinese EVs, 50% on solar cells and 25% on steel, aluminum, EV batteries and key minerals ...
Android Authority20d
T-Mobile vs Verizon: Which carrier is better for you?
For years, T-Mobile has been the third-largest US carrier, and the Sprint merger only solidified its position. The Un-Carrier’s goal is to become America’s leading carrier, and we’re here to ...